Brookstone Capital Management’s iShares iBonds Dec 2025 Term Corporate ETF IBDQ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-29,768
Closed -$750K 1199
2025
Q3
$750K Sell
29,768
-3,564
-11% -$89.6K 0.01% 695
2025
Q2
$839K Buy
33,332
+1,482
+5% +$37.2K 0.01% 610
2025
Q1
$801K Sell
31,850
-46
-0.1% -$1.16K 0.01% 600
2024
Q4
$799K Buy
31,896
+4,981
+19% +$125K 0.01% 585
2024
Q3
$676K Buy
26,915
+6,491
+32% +$162K 0.01% 613
2024
Q2
$508K Buy
20,424
+4,098
+25% +$102K 0.01% 652
2024
Q1
$405K Buy
+16,326
New +$404K 0.01% 676

Other funds holding IBDQ

Brookstone Capital Management's IBDQ Position: Q4 2025 in Review

Brookstone Capital Management sold out of iShares iBonds Dec 2025 Term Corporate ETF (IBDQ) in Q4 2025, closing a stake of 29,768 shares — an estimated $750K sold.

Brookstone Capital Management first reported a position in IBDQ in Q1 2024 and held it in 7 quarters. The position peaked at $839K in Q2 2025. 3 funds tracked by Wall St. Rank hold IBDQ as of Q4 2025.

  • Brookstone Capital Management reported no remaining iShares iBonds Dec 2025 Term Corporate ETF position as of Q4 2025 after selling out during the quarter.
  • Brookstone Capital Management sold 29,768 iShares iBonds Dec 2025 Term Corporate ETF shares in Q4 2025, an estimated $750K.
  • Brookstone Capital Management first reported a position in iShares iBonds Dec 2025 Term Corporate ETF in Q1 2024 and held it in 7 quarters.
  • Brookstone Capital Management's iShares iBonds Dec 2025 Term Corporate ETF position peaked at $839K in Q2 2025.
  • 3 funds tracked by Wall St. Rank held iShares iBonds Dec 2025 Term Corporate ETF as of Q4 2025.

Based on Brookstone Capital Management's 13F filing for Q4 2025, filed 15 Jan 2026.